Clinical trials: Retroperitoneal Neoplasms

Sarcoma

Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas

• Terminated
• Age: 18 years and older
• Phase 2
• Results posted

The goal of this clinical research study is to learn if the study drug RAD001 can stop or slow the growth of resectable soft tissue sarcoma.

Trial name

NCT01048723

Testing

RAD001

Where

United States

Volunteers

2 people

Sponsor

H. Lee Moffitt Cancer Center and Research Institute